Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Choledochal cysts: a ten year experience

S Y Rha1, M C Stovroff, P L Glick

  • 1Division of Pediatric Surgery, Children's Hospital of Buffalo, New York, USA.

The American Surgeon
|January 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Global prevalence of FGFR2b protein overexpression in advanced gastric cancer and gastroesophageal junction cancers: pooled analysis of two bemarituzumab phase III studies.

ESMO open·2026
Same author

Clinicopathologic characteristics and genomic profiling of HER2-low advanced gastric or gastroesophageal junction cancer.

ESMO open·2026
Same author

Surrogate endpoints for survival in KEYNOTE-585: neoadjuvant/adjuvant pembrolizumab plus chemotherapy versus placebo plus chemotherapy for gastric or gastroesophageal junction adenocarcinoma.

ESMO open·2026
Same author

Pembrolizumab with trastuzumab and chemotherapy for HER2-positive advanced gastric cancer: health-related quality-of-life analysis from the randomized KEYNOTE-811 trial.

ESMO open·2025
Same author

Generation of a Ym1 deficient mouse utilising CRISPR-Cas9 in CB6 embryos.

Transgenic research·2025
Same author

Corrigendum to "An open-label, phase IB/II study of abemaciclib with paclitaxel for tumors with CDK4/6 pathway genomic alterations": [ESMO Open 10 (2025) 104106].

ESMO open·2025

Early diagnosis of choledochal cysts (CC) through prenatal ultrasonography enables prompt surgical intervention. Complete cyst excision and hepaticojejunostomy remain the preferred treatment for choledochal cysts, ensuring symptom-free outcomes.

Area of Science:

  • Pediatric Surgery
  • Gastroenterology
  • Medical Imaging

Background:

  • Choledochal cyst (CC) is a rare congenital anomaly often diagnosed in childhood.
  • Prognosis is significantly influenced by early detection, complete surgical excision, and reconstruction.
  • This study reviews a decade of management experience, highlighting recent advancements.

Purpose of the Study:

  • To evaluate the 10-year experience in managing choledochal cysts.
  • To emphasize innovations in diagnosis and surgical treatment.
  • To assess the long-term outcomes of surgical management.

Main Methods:

  • Retrospective analysis of 16 patients with choledochal cysts treated over 10 years.
  • Classification of cysts by type (1, 3, and 4).

Related Experiment Videos

  • Surgical procedures included cyst excision with Roux-en-Y hepaticojejunostomy or sphincteroplasty.

    • Main Results:

    • 16 patients (M:F ratio 1:4) presented with CC at a mean age of 3 years.
    • Two presentation groups: neonatal (7 patients) and older children with cholangitis (9 patients).
    • All patients achieved symptom-free status post-surgery; 4 cases diagnosed prenatally via ultrasonography.

    Conclusions:

    • Complete excision of choledochal cysts with primary hepatico-enteric anastomosis is the gold standard treatment.
    • Prenatal ultrasonography is highly effective for early CC diagnosis, facilitating planned neonatal surgery and preventing complications.